chr4-46041008-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000295452.5(GABRG1):c.1378G>A(p.Val460Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000962 in 1,611,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000295452.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRG1 | NM_173536.4 | c.1378G>A | p.Val460Ile | missense_variant | 9/9 | ENST00000295452.5 | NP_775807.2 | |
GABRG1 | XM_017007990.2 | c.991G>A | p.Val331Ile | missense_variant | 7/7 | XP_016863479.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GABRG1 | ENST00000295452.5 | c.1378G>A | p.Val460Ile | missense_variant | 9/9 | 1 | NM_173536.4 | ENSP00000295452 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000401 AC: 61AN: 151964Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000136 AC: 34AN: 249336Hom.: 0 AF XY: 0.000111 AC XY: 15AN XY: 134746
GnomAD4 exome AF: 0.0000644 AC: 94AN: 1459684Hom.: 0 Cov.: 31 AF XY: 0.0000730 AC XY: 53AN XY: 726096
GnomAD4 genome AF: 0.000401 AC: 61AN: 152082Hom.: 0 Cov.: 32 AF XY: 0.000404 AC XY: 30AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 25, 2023 | The c.1378G>A (p.V460I) alteration is located in exon 9 (coding exon 9) of the GABRG1 gene. This alteration results from a G to A substitution at nucleotide position 1378, causing the valine (V) at amino acid position 460 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at